21 citations
,
September 2021 in “Fertility and Sterility” A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.
8 citations
,
June 2016 in “Journal of Cosmetic Dermatology” Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.
53 citations
,
February 2022 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism” AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.
9 citations
,
November 2014 in “Indian Journal of Endocrinology and Metabolism” This document reported a rare case of a 15-year-old female with both 46,XX gonadal dysgenesis and MRKH syndrome, characterized by primary amenorrhea, absence of secondary sexual characteristics, and congenital absence of the uterus and upper vagina. Despite normal intelligence and no family history of similar conditions, the patient exhibited elevated follicle-stimulating and luteinizing hormone levels with low estradiol, indicating hypergonadotropic hypogonadism. Hormonal therapy with ethinyl estradiol was initiated to develop secondary sexual characteristics and prevent osteoporosis, but infertility remained unresolved. The document discussed the potential embryological and genetic factors contributing to these conditions, including the role of estrogens and antimullerian hormone receptors.
5 citations
,
April 2014 in “European Journal of Obstetrics & Gynecology and Reproductive Biology” AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.